1. An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes. Issue 5 (14th May 2015) Authors: Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza; Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y Journal: Journal of leukocyte biology Issue: Volume 98:Issue 5(2015) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An increased expression of PI‐PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes. Issue 5 (14th May 2015) Authors: Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza; Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y. Journal: Journal of leukocyte biology Issue: Volume 98:Issue 5(2015) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia. (30th December 2021) Authors: Ravaioli, Federico; Marconi, Giovanni; Martinelli, Giovanni; Dajti, Elton; Sartor, Chiara; Abbenante, Maria Chiara; Alemanni, Luigina Vanessa; Nanni, Jacopo; Rossini, Benedetta; Parisi, Sarah; Colecchia, Luigi; Cristiano, Gianluca; Marasco, Giovanni; Vestito, Amanda; Paolini, Stefania; Bonifazi, ... Journal: Cancer medicine Issue: Volume 11:Number 3(2022) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment. Issue 4 (5th June 2022) Authors: Sartor, Chiara; Arpinati, Mario; Chirumbolo, Gabriella; Dozza, Luca; Cristiano, Gianluca; Nanni, Jacopo; Marconi, Giovanni; Robustelli, Valentina; Vigliotta, Ilaria; Parisi, Sarah; Terragna, Carolina; Testoni, Nicoletta; Paolini, Stefania; Martinelli, Giovanni; Curti, Antonio; Cavo, Michele; Papa... Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Current therapy and new drugs: a road to personalized treatment of myelodysplastic syndromes. Issue 1 (2nd January 2018) Authors: Parisi, Sarah; Ratti, Stefano; Mongiorgi, Sara; Suh, Pann-Ghill; Manzoli, Lucia; McCubrey, James A.; Cocco, Lucio; Follo, Matilde Y.; Finelli, Carlo Journal: Expert review of precision medicine and drug development Issue: Volume 3:Issue 1(2018) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML. (11th December 2016) Authors: Tenti, Elena; Papayannidis, Cristina; Marconi, Giovanni; Parisi, Sarah; Simonetti, Giorgia; Paolini, Stefania; Sartor, Chiara; Ottaviani, Emanuela; Testoni, Nicoletta; Martinelli, Giovanni Journal: Expert opinion on pharmacotherapy Issue: Volume 17:Number 18(2016) Page Start: 2479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights. Issue 5 (4th May 2022) Authors: Finelli, Carlo; Parisi, Sarah; Paolini, Stefania Journal: Expert review of hematology Issue: Volume 15:Issue 5(2022) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents. (28th February 2022) Authors: Papayannidis, Cristina; Nanni, Jacopo; Cristiano, Gianluca; Marconi, Giovanni; Sartor, Chiara; Parisi, Sarah; Zannoni, Letizia; Saed, Rashed; Ottaviani, Emanuela; Bandini, Lorenza; Testoni, Nicoletta; Baldazzi, Carmen; Solli, Vincenza; Ricci, Paolo; Di Giovanni Bezzi, Chiara; Abd‐alatif, Rania; S... Journal: European journal of haematology Issue: Volume 108:Number 6(2022) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant. Issue 4 (7th May 2021) Authors: Papayannidis, Cristina; Sartor, Chiara; Dominietto, Alida; Zappone, Elisabetta; Arpinati, Mario; Marconi, Giovanni; Cristiano, Gianluca; Nanni, Jacopo; Parisi, Sarah; Barbato, Francesco; Paolini, Stefania; Soverini, Simona; Terragna, Carolina; Robustelli, Valentina; Testoni, Nicoletta; Chirumbolo... Journal: Hematological oncology Issue: Volume 39:Issue 4(2021) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia. (7th April 2020) Authors: Marconi, Giovanni; Talami, Annalisa; Abbenante, Maria Chiara; Sartor, Chiara; Parisi, Sarah; Nanni, Jacopo; Bertamini, Luca; Ragaini, Simone; Olivi, Matteo; de Polo, Stefano; Cristiano, Gianluca; Fontana, Maria Chiara; Bochicchio, Maria Teresa; Ottaviani, Emanuela; Arpinati, Mario; Sessa, Mariaro... Journal: European journal of haematology Issue: Volume 105:Number 1(2020) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗